712
Participants
Start Date
April 20, 2023
Primary Completion Date
October 31, 2026
Study Completion Date
December 1, 2026
Participant Cohort
Patients coming to the facility for chest x-rays for any reason, will undergo x-rays as ordered by their treating clinician. In case of any nodule detection by qXR, it will be classified either as low-risk (Lung nodule malignancy score ) LNMS or high-risk LNMS confirmed by radiologist. Then if patient is eligible will be included in the study and a CT Scan will be requested upon enrolment of the patient.
Research Site, Mexico City
Research Site, Mersin
Research Site, Surabaya
Research Site, Monterrey
Research Site, New Delhi
Research Site, New Delhi
Research Site, Gurugram
Research Site, New Delhi
Research Site, Mumbai
Research Site, Pune
Research Site, Hyderabad
Research Site, Bangalore
Research Site, Bangalore
Research Site, Chennai
Research Site, Chennai
Research Site, Chennai
Research Site, Chennai
Research Site, Chennai
Research Site, Kolkata
Research Site, Alexandria
Research Site, Cairo
Research Site, Ankara
Lead Sponsor
AstraZeneca
INDUSTRY